Literature DB >> 20974567

SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma.

Miguel Pastor Borgoñón1, Ricard Mesía Nin, Juan Jesús Cruz Hernández, Dolores Isla Casado.   

Abstract

Nasopharyngeal carcinoma is an unusual tumour in Spain. It has differences in epidemiology, histology, clinical behaviour, treatment and prognosis from those of other head and neck neoplasms, which justifies separate analysis. It is a neoplasm with a high possibility of cure with a combined treatment if even it is diagnosed in an advanced locoregional stage (stage III or IV, without metastasis). The multidisciplinary team, bringing together all professionals who specialize in the diagnosis and treatment of these tumors make the decision to establish the best sequence of individualized diagnosis, staging and treatment for each patient. This guide gives recommendations for diagnosis, staging and treatment for nasopharyngeal carcinoma. The treatment recommendations are summarized as local disease, locally advance and recurrent and metastatic disease.

Entities:  

Mesh:

Year:  2010        PMID: 20974567     DOI: 10.1007/s12094-010-0590-9

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  5 in total

Review 1.  Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.

Authors:  Bertrand Baujat; Hélène Audry; Jean Bourhis; Anthony T C Chan; Haluk Onat; Daniel T T Chua; Dora L W Kwong; Muhyi Al-Sarraf; Kwan-Hwa Chi; Masato Hareyama; Sing F Leung; Kullathorn Thephamongkhol; Jean-Pierre Pignon
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-01-01       Impact factor: 7.038

2.  Combined radiotherapy and chemotherapy for nasopharyngeal carcinoma.

Authors:  K K Fu
Journal:  Semin Radiat Oncol       Date:  1998-10       Impact factor: 5.934

3.  Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

Authors:  M Al-Sarraf; M LeBlanc; P G Giri; K K Fu; J Cooper; T Vuong; A A Forastiere; G Adams; W A Sakr; D E Schuller; J F Ensley
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

4.  Influence of [18F] fluorodeoxyglucose positron emission tomography on salvage treatment decision making for locally persistent nasopharyngeal carcinoma.

Authors:  Xiao-Kang Zheng; Long-Hua Chen; Quan-Shi Wang; Fu-Bing Wu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-05-26       Impact factor: 7.038

5.  The World Health Organization histological classification of tumours of the upper respiratory tract and ear. A commentary on the second edition.

Authors:  K Shanmugaratnam; L H Sobin
Journal:  Cancer       Date:  1993-04-15       Impact factor: 6.860

  5 in total
  2 in total

1.  The relevance of the Spanish Society for Medical Oncology (SEOM)'s clinical oncology guidelines.

Authors:  Dolores Isla Casado; Antonio González-Martín; Emilio Alba Conejo
Journal:  Clin Transl Oncol       Date:  2010-11       Impact factor: 3.405

2.  Effectiveness and toxicity of helical tomotherapy for patients with locally recurrent nasopharyngeal carcinoma.

Authors:  F Puebla; J L Lopez Guerra; J M Garcia Ramirez; R Matute; I Marrone; C Miguez; D Sevillano; A Sanchez-Reyes; E Rivin Del Campo; J M Praena-Fernandez; I Azinovic
Journal:  Clin Transl Oncol       Date:  2015-06-25       Impact factor: 3.405

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.